Why most peptide drugs are shots
A swallowed peptide is digested like food, so most peptide drugs are injected. The few pills work through clever chemistry, or by not being peptides at all.
Transcript and sources
- Almost every peptide drug is an injection. So why can't you just swallow the pill?
- Because your gut treats a swallowed peptide like food. Enzymes in the stomach and small intestine cut it into amino acids and tiny fragments, so usually less than one percent reaches the blood.
- Size matters too. Aspirin weighs about one hundred eighty daltons. Semaglutide, about four thousand one hundred. Insulin, about five thousand eight hundred. An antibody, about a hundred and forty-eight thousand.
- So drugmakers inject. Under the skin, about eighty-nine percent of semaglutide reaches the blood, and it lasts about a week.
- In two thousand nineteen, Rybelsus became the first GLP-1 medicine you could swallow. Its trick is a helper called SNAC, which briefly buffers the acid around the tablet and shields the drug from digestive enzymes.
- Even so, only about one percent gets in. That's why the label says: empty stomach, a small sip of water, then wait thirty minutes before eating.
- In April two thousand twenty-six, the FDA approved orforglipron, sold as Foundayo: a GLP-1 pill that isn't a peptide at all. It's a small molecule that fits the same receptor, and it can be taken with or without food.
- A few peptides do work by mouth, but they're the exception. For BPC-157 capsules, the FDA found no human data on what happens when it's swallowed.
- Shots aren't tradition. They're chemistry. See how every peptide is delivered, at peplexicon.com.
Sources
- Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020
- Brayden DJ, et al. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Adv Drug Deliv Rev. 2020
- Lipinski CA, et al. Experimental and computational approaches to estimate solubility and permeability… Adv Drug Deliv Rev. 2001
- Ozempic (semaglutide) injection prescribing information, DailyMed (rev. June 2026)
- Rybelsus and Ozempic tablets (semaglutide) prescribing information, DailyMed (effective 30 Jan 2026)
- Buckley ST, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018
- Wegovy (semaglutide) injection and tablets prescribing information, DailyMed (effective 18 Jun 2026)
- Foundayo (orforglipron) prescribing information, DailyMed (effective 29 Jul 2026)
- FDA press announcement. FDA approves first new molecular entity under National Priority Voucher program. 1 Apr 2026
- DDAVP (desmopressin acetate) tablets prescribing information, DailyMed
- Sandimmune (cyclosporine) prescribing information, DailyMed (rev. Mar 2026)
- FDA. Briefing Document, PCAC 23–24 Jul 2026: BPC-157-related bulk drug substances (memo dated 11 May 2026)